Blacklock's Reporter

A federal judge has struck a drug consumers’ protection regulation that was to take effect January 1. Seventeen pharmaceutical companies successfully challenged a cabinet order intended to lower costs of medication through the Patented Medicine Prices Review Board: “The Board does not regulate profits.”